Study S001884

A Single-center,Proof of Concept,Randomized,Controlled Parallel Group Clinical Trial of the Effects of Exenatide vs. a Long Acting Insulin Analog to Evaluate the Efficacy of Exenatide in Patients With Diabetic Neuropathy and Type 2 Diabetes

ClinicalTrials.gov record

Registration

Registration: NCT00855439
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: NONE
Status: COMPLETED
Enrollment: 46
Start: 2008-06
Primary completion: 2014-05
Lead sponsor: University of Michigan
Conditions: Type 2 Diabetes Mellitus; Diabetic Peripheral Neuropathy
Interventions: DRUG:Exenatide; DRUG:Glargine
Results posted: TRUE
Individual participant data sharing: NO

Registered primary outcomes

Confirmed Clinical Neuropathy (CCN) [18 Months]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0020700	Effects of exenatide on measures of diabetic neuropathy in subjects with type 2 diabetes: results from an 18-month proof-of-concept open-label randomized study. Jaiswal M, Journal of diabetes and its complications	2015	Randomized trial	PMID 26264399 DOI	cites ClinicalTrials.gov:NCT00855439; registry reference DERIVED:26264399